1. National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys
2. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, et al. (2009) The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary on ART terminology, 2009. Hum Reprod 24: 2683–2687 doi:10.1093/humrep/dep343. [PubMed]
3. World Health Organization (2006) Reproductive health indicators for global monitoring: guidelines for their generation, interpretation and analysis for global monitoring. Geneva: World Health Organization. 63 p.
4. Rowe PJ, Comhaire FH, Hargreave TB, Mellows HJ, Press CU (1993) WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge: Cambridge University Press.
5. TAHIR, F., SHAHAB, M., AFZAL, M., SUBHAN, F., SULTAN, S., KAZI, B. M. AND DIL, A.S., 2004. Male reproductive health: An important segment towards improving reproductive health of a couple. In: Population research and policy development in Pakistan (eds. M.A. Chaudhry and M. Desousa), pp. 227-248. Population Association of Pakistan, Islamabad, Pakistan.
7. RAZZAK, A.H. AND WAIS, S.A., 2002. The infertile couple: a cohort study in Duhok, Iraq. East Mediterr. Hlth. J., 8: 234-238
8. Safarinejad MR. Infertility among couples in a population‐based study in Iran: prevalence and associated risk factors. Int J Androl 2008; 31: 303- 314
9. Psycho-Social Consequences of Secondary Infertility in Karachi. Neelofar Sami (Department of Community Health Sciences, Aga Khan University, Karachi. )
Tazeen Saeed Ali (Department of Community Health Sciences, Aga Khan University, Karachi.)
10. Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod. 2000;15:2341–6
11. Van Loendersloot LL, van Wely M, Limpens J, Bossuyt PM, Repping S, van der Veen F. Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis. Hum Reprod Update. 2010;16:577–89.
12. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-62.
13. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571-6.
15. Barbakadze L, Kristesashvili J, Khonelidze N, Tsagareishvili G. The Correlations of Anti-Mullerian Hormone, Follicle-Stimulating Hormone and Antral Follicle Count in Different Age Groups of Infertile Women. Int J Fertil Steril 2015; 8: 393-398.
16. Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001;16:868–70.
17. Craft I, Gorgy A, Hill J, Menon D, Podsiadly B. Will GnRH antagonists provide new hope for patients considered "difficult responders" to GnRH agonist protocols? Hum Reprod 1999;14:2959–62.
18. Eichenlaub-Ritter U. Genetics of oocyte ageing. Maturitas 1998;30: 143–69.
19. Hull MGR, Fleming CF, Hughes AO, McDermott A. The age-related decline in female fecundity: A quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization. Fertil Steril 1996; 65:783-90.
20. Viardot-Foucault V, Tai BC, Oo SY, et al. Cumulative success rates after IVF treatment: longitudinal study from a single centre. Reproductive Endocrinology and ART: A celebratory congress. Canada, 2011.